Rank | Gene Set | Z-score |
---|---|---|
1 | cellular anion homeostasis (GO:0030002) | 5.63894547 |
2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.56035406 |
3 | cytidine deamination (GO:0009972) | 5.42630282 |
4 | cytidine metabolic process (GO:0046087) | 5.42630282 |
5 | cytidine catabolic process (GO:0006216) | 5.42630282 |
6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.74089420 |
7 | necroptotic process (GO:0070266) | 4.31103513 |
8 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.21650429 |
9 | cellular ketone body metabolic process (GO:0046950) | 4.20515747 |
10 | secondary heart field specification (GO:0003139) | 4.07929675 |
11 | heart field specification (GO:0003128) | 4.07929675 |
12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.05617562 |
13 | fucose catabolic process (GO:0019317) | 4.04931828 |
14 | L-fucose metabolic process (GO:0042354) | 4.04931828 |
15 | L-fucose catabolic process (GO:0042355) | 4.04931828 |
16 | positive regulation of fibroblast migration (GO:0010763) | 3.99726955 |
17 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.98878903 |
18 | drug catabolic process (GO:0042737) | 3.98217086 |
19 | ribosomal small subunit assembly (GO:0000028) | 3.87727225 |
20 | exogenous drug catabolic process (GO:0042738) | 3.78744640 |
21 | ketone body metabolic process (GO:1902224) | 3.78569707 |
22 | behavioral response to nicotine (GO:0035095) | 3.66652615 |
23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.65284406 |
24 | ATP synthesis coupled proton transport (GO:0015986) | 3.64796020 |
25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.64796020 |
26 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.63573206 |
27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57447197 |
28 | positive regulation of cell fate commitment (GO:0010455) | 3.56804056 |
29 | sequestering of actin monomers (GO:0042989) | 3.56030175 |
30 | positive regulation of defense response to virus by host (GO:0002230) | 3.55669338 |
31 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.55449167 |
32 | respiratory electron transport chain (GO:0022904) | 3.53055942 |
33 | positive regulation of interleukin-17 production (GO:0032740) | 3.47631106 |
34 | electron transport chain (GO:0022900) | 3.44598989 |
35 | growth hormone receptor signaling pathway (GO:0060396) | 3.44376997 |
36 | alkaloid metabolic process (GO:0009820) | 3.43439201 |
37 | somite rostral/caudal axis specification (GO:0032525) | 3.39911319 |
38 | neutrophil activation involved in immune response (GO:0002283) | 3.39272649 |
39 | platelet dense granule organization (GO:0060155) | 3.38497014 |
40 | epoxygenase P450 pathway (GO:0019373) | 3.31351054 |
41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30005117 |
42 | protein complex biogenesis (GO:0070271) | 3.29203942 |
43 | oxidative demethylation (GO:0070989) | 3.26110119 |
44 | intracellular pH reduction (GO:0051452) | 3.25906804 |
45 | protein neddylation (GO:0045116) | 3.22634205 |
46 | signal peptide processing (GO:0006465) | 3.15144826 |
47 | aldehyde catabolic process (GO:0046185) | 3.14253248 |
48 | viral transcription (GO:0019083) | 3.12616822 |
49 | proteasome assembly (GO:0043248) | 3.12277674 |
50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.09818718 |
51 | NADH dehydrogenase complex assembly (GO:0010257) | 3.09818718 |
52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.09818718 |
53 | chaperone-mediated protein transport (GO:0072321) | 3.09427471 |
54 | ribosomal small subunit biogenesis (GO:0042274) | 3.08570823 |
55 | positive regulation of prostaglandin secretion (GO:0032308) | 3.07384492 |
56 | type I interferon signaling pathway (GO:0060337) | 3.06533270 |
57 | cellular response to type I interferon (GO:0071357) | 3.06533270 |
58 | sleep (GO:0030431) | 3.06338112 |
59 | cellular response to interferon-beta (GO:0035458) | 3.05618743 |
60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.04440513 |
61 | respiratory chain complex IV assembly (GO:0008535) | 3.04137573 |
62 | cellular response to growth hormone stimulus (GO:0071378) | 3.03235001 |
63 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.01591331 |
64 | cotranslational protein targeting to membrane (GO:0006613) | 3.00933822 |
65 | response to type I interferon (GO:0034340) | 2.98819016 |
66 | cytochrome complex assembly (GO:0017004) | 2.98032727 |
67 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.97055434 |
68 | response to interferon-beta (GO:0035456) | 2.95121898 |
69 | programmed necrotic cell death (GO:0097300) | 2.94889025 |
70 | translational termination (GO:0006415) | 2.94571962 |
71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.93843608 |
72 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.93693051 |
73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.93143273 |
74 | L-phenylalanine catabolic process (GO:0006559) | 2.93143273 |
75 | adaptation of signaling pathway (GO:0023058) | 2.93042536 |
76 | protein targeting to ER (GO:0045047) | 2.92725949 |
77 | respiratory burst (GO:0045730) | 2.92668503 |
78 | negative regulation of telomere maintenance (GO:0032205) | 2.91476651 |
79 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.90793848 |
80 | regulation of mesoderm development (GO:2000380) | 2.88305369 |
81 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.87993766 |
82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85912735 |
83 | protein localization to endoplasmic reticulum (GO:0070972) | 2.83905318 |
84 | DNA deamination (GO:0045006) | 2.83880263 |
85 | T cell apoptotic process (GO:0070231) | 2.83274626 |
86 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.82756783 |
87 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.82654047 |
88 | positive regulation of fatty acid transport (GO:2000193) | 2.80767210 |
89 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.78202233 |
90 | necrotic cell death (GO:0070265) | 2.77809649 |
91 | negative regulation of cell fate specification (GO:0009996) | 2.77071932 |
92 | aggressive behavior (GO:0002118) | 2.77029613 |
93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.75030110 |
94 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74700362 |
95 | inositol phosphate catabolic process (GO:0071545) | 2.73697676 |
96 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.73547635 |
97 | T cell migration (GO:0072678) | 2.71817186 |
98 | regulation of neurotransmitter uptake (GO:0051580) | 2.71652399 |
99 | inositol phosphate dephosphorylation (GO:0046855) | 2.70063356 |
100 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.70063356 |
101 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.69813564 |
102 | lymphocyte apoptotic process (GO:0070227) | 2.69705383 |
103 | cardiac ventricle formation (GO:0003211) | 2.68136915 |
104 | positive regulation of icosanoid secretion (GO:0032305) | 2.67480169 |
105 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.66661654 |
106 | regulation of metalloenzyme activity (GO:0048552) | 2.65630032 |
107 | regulation of antigen processing and presentation (GO:0002577) | 2.65242607 |
108 | dopamine transport (GO:0015872) | 2.65162487 |
109 | response to pheromone (GO:0019236) | 2.64417345 |
110 | pH reduction (GO:0045851) | 2.63063436 |
111 | specification of organ identity (GO:0010092) | 2.63052611 |
112 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62613217 |
113 | mast cell activation (GO:0045576) | 2.62462580 |
114 | eosinophil chemotaxis (GO:0048245) | 2.61936394 |
115 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.61759162 |
116 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.61123095 |
117 | superoxide anion generation (GO:0042554) | 2.60651672 |
118 | aromatic amino acid family catabolic process (GO:0009074) | 2.60013530 |
119 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59935683 |
120 | vitamin biosynthetic process (GO:0009110) | 2.58161583 |
121 | indolalkylamine metabolic process (GO:0006586) | 2.57638254 |
122 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57500828 |
123 | positive regulation of protein homodimerization activity (GO:0090073) | 2.57388207 |
124 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.57311595 |
125 | cell migration involved in heart development (GO:0060973) | 2.57034050 |
126 | reactive oxygen species biosynthetic process (GO:1903409) | 2.56721596 |
127 | positive regulation of T cell migration (GO:2000406) | 2.55326416 |
128 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.54518996 |
129 | positive regulation of humoral immune response (GO:0002922) | 2.54338096 |
130 | dendritic cell chemotaxis (GO:0002407) | 2.53847004 |
131 | NAD biosynthetic process (GO:0009435) | 2.53725133 |
132 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.52684317 |
133 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52345231 |
134 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.51683714 |
135 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.51683714 |
136 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.51601142 |
137 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51559113 |
138 | positive regulation of DNA recombination (GO:0045911) | 2.51439515 |
139 | extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) | 2.51040666 |
140 | cytokine biosynthetic process (GO:0042089) | 2.50838770 |
141 | regulation of glucokinase activity (GO:0033131) | 2.50740953 |
142 | regulation of hexokinase activity (GO:1903299) | 2.50740953 |
143 | regulation of T cell migration (GO:2000404) | 2.49571651 |
144 | leukocyte aggregation (GO:0070486) | 2.49454113 |
145 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.48598432 |
146 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.48135591 |
147 | polyol catabolic process (GO:0046174) | 2.48068698 |
148 | GTP biosynthetic process (GO:0006183) | 2.47630371 |
149 | regulation of activation of Janus kinase activity (GO:0010533) | 2.47493980 |
150 | response to peptidoglycan (GO:0032494) | 2.47436190 |
151 | response to misfolded protein (GO:0051788) | 2.47065722 |
152 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.46626211 |
153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46528383 |
154 | T-helper 1 type immune response (GO:0042088) | 2.46489360 |
155 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.46248719 |
156 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.46248719 |
157 | negative T cell selection (GO:0043383) | 2.46217564 |
158 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45676893 |
159 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.44331679 |
160 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.44147513 |
161 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.43279515 |
162 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.43145406 |
163 | positive regulation of B cell mediated immunity (GO:0002714) | 2.42574388 |
164 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.42574388 |
165 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.41912713 |
166 | ribosomal large subunit biogenesis (GO:0042273) | 2.41871612 |
167 | neutrophil activation (GO:0042119) | 2.40930308 |
168 | translational elongation (GO:0006414) | 2.38310392 |
169 | xenobiotic catabolic process (GO:0042178) | 2.38295035 |
170 | epithelial cilium movement (GO:0003351) | 2.37883800 |
171 | piRNA metabolic process (GO:0034587) | 2.37873528 |
172 | sulfation (GO:0051923) | 2.37636406 |
173 | axoneme assembly (GO:0035082) | 2.37503680 |
174 | interferon-gamma production (GO:0032609) | 2.37216972 |
175 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35058038 |
176 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.35058038 |
177 | cellular response to interleukin-15 (GO:0071350) | 2.34684996 |
178 | negative regulation of viral genome replication (GO:0045071) | 2.34212626 |
179 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.33889296 |
180 | regulation of RIG-I signaling pathway (GO:0039535) | 2.33789423 |
181 | granulocyte activation (GO:0036230) | 2.33713325 |
182 | viral life cycle (GO:0019058) | 2.33642780 |
183 | negative thymic T cell selection (GO:0045060) | 2.33023619 |
184 | termination of RNA polymerase III transcription (GO:0006386) | 2.29705658 |
185 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.29705658 |
186 | positive regulation of lymphocyte migration (GO:2000403) | 2.29347320 |
187 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.29342587 |
188 | amyloid precursor protein catabolic process (GO:0042987) | 2.29087128 |
189 | eosinophil migration (GO:0072677) | 2.28747655 |
190 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.28370549 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.70852760 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.46384275 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.10300412 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.95122278 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83981203 |
6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.68965701 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.62052463 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21444025 |
9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.18999712 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.14561616 |
11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.06743166 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.01140327 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.99201519 |
14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.86312646 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.81975947 |
16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71370081 |
17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.68922305 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60594168 |
19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.47704561 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45764327 |
21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.41446669 |
22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.40831305 |
23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.25014467 |
24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20232432 |
25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10211830 |
26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.06666473 |
27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.03146893 |
28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98707388 |
29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88896555 |
30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82264631 |
31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81462179 |
32 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78693769 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74215927 |
34 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.69552490 |
35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.68080308 |
36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.67709849 |
37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66711676 |
38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63840545 |
39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.63025500 |
40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62397022 |
41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.61653099 |
42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60588463 |
43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.60346244 |
44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.58946428 |
45 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57233824 |
46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55031105 |
47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54433192 |
48 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.52923028 |
49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51609382 |
50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50877558 |
51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.49308824 |
52 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.49308824 |
53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47483584 |
54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45700693 |
55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45604309 |
56 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.45211799 |
57 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.44283704 |
58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44098839 |
59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43803231 |
60 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.43116336 |
61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38177673 |
62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38059043 |
63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37086434 |
64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36555451 |
65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35638341 |
66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.34712317 |
67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32597512 |
68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32597512 |
69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.32243803 |
70 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31660983 |
71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31375334 |
72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29853106 |
73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27080242 |
74 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24165497 |
75 | AR_20517297_ChIP-Seq_VCAP_Human | 1.20759913 |
76 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18965566 |
77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18778755 |
78 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18598007 |
79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18384972 |
80 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17681618 |
81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17406810 |
82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17406810 |
83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.16514607 |
84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.15976918 |
85 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15685960 |
86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15042934 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14926131 |
88 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.14321937 |
89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14142178 |
90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13806469 |
91 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13731699 |
92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.13718005 |
93 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.13360824 |
94 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12640141 |
95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12226162 |
96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10901259 |
97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10832028 |
98 | ERA_21632823_ChIP-Seq_H3396_Human | 1.09382915 |
99 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09138110 |
100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.09135099 |
101 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07625341 |
102 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07059903 |
103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06954166 |
104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06932932 |
105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06574399 |
106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05338148 |
107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05280358 |
108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04617705 |
109 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.04469449 |
110 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03403424 |
111 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03001430 |
112 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02241715 |
113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01438813 |
114 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00534882 |
115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99815510 |
116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99026001 |
117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98852639 |
118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98347375 |
119 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97084465 |
120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97058032 |
121 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96873990 |
122 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.96648371 |
123 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96569114 |
124 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96541386 |
125 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95925060 |
126 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95724296 |
127 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95692077 |
128 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95319572 |
129 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95311194 |
130 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95297745 |
131 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95077262 |
132 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94218442 |
133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94188993 |
134 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92934902 |
135 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92864683 |
136 | MYB_26560356_Chip-Seq_TH2_Human | 0.92715318 |
137 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92091941 |
138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92064676 |
139 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.91804642 |
140 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.88874073 |
141 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.87991326 |
142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87980220 |
143 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87493255 |
144 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87350549 |
145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86706032 |
146 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.86508713 |
147 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.86241289 |
148 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84882303 |
149 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84633421 |
150 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83858159 |
151 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83483593 |
152 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82565070 |
153 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82054426 |
154 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.81841789 |
155 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81209174 |
156 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.81135047 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.98092533 |
2 | MP0005671_abnormal_response_to | 3.41990165 |
3 | MP0003724_increased_susceptibility_to | 3.38642307 |
4 | MP0009785_altered_susceptibility_to | 3.35855098 |
5 | MP0002234_abnormal_pharynx_morphology | 3.33464816 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.17091480 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 2.91464020 |
8 | MP0001873_stomach_inflammation | 2.65954227 |
9 | MP0005000_abnormal_immune_tolerance | 2.54721043 |
10 | MP0005025_abnormal_response_to | 2.48403398 |
11 | MP0000685_abnormal_immune_system | 2.41042902 |
12 | MP0005645_abnormal_hypothalamus_physiol | 2.40172773 |
13 | MP0009379_abnormal_foot_pigmentation | 2.37288988 |
14 | MP0005387_immune_system_phenotype | 2.36486541 |
15 | MP0001790_abnormal_immune_system | 2.36486541 |
16 | MP0005646_abnormal_pituitary_gland | 2.23976868 |
17 | MP0003436_decreased_susceptibility_to | 2.22434664 |
18 | MP0001800_abnormal_humoral_immune | 2.20830843 |
19 | MP0002723_abnormal_immune_serum | 2.15252569 |
20 | MP0002419_abnormal_innate_immunity | 2.10118829 |
21 | MP0006082_CNS_inflammation | 2.09966716 |
22 | MP0003787_abnormal_imprinting | 2.05364153 |
23 | MP0001986_abnormal_taste_sensitivity | 2.04902277 |
24 | MP0003763_abnormal_thymus_physiology | 1.99651501 |
25 | MP0002452_abnormal_antigen_presenting | 1.97205033 |
26 | MP0001819_abnormal_immune_cell | 1.95417657 |
27 | MP0002420_abnormal_adaptive_immunity | 1.95338109 |
28 | MP0004381_abnormal_hair_follicle | 1.91694640 |
29 | MP0008877_abnormal_DNA_methylation | 1.87453032 |
30 | MP0008872_abnormal_physiological_respon | 1.85851031 |
31 | MP0002163_abnormal_gland_morphology | 1.83877315 |
32 | MP0010386_abnormal_urinary_bladder | 1.81951671 |
33 | MP0000465_gastrointestinal_hemorrhage | 1.81291254 |
34 | MP0002876_abnormal_thyroid_physiology | 1.79023152 |
35 | MP0001529_abnormal_vocalization | 1.74561493 |
36 | MP0001905_abnormal_dopamine_level | 1.73970798 |
37 | MP0005451_abnormal_body_composition | 1.73419250 |
38 | MP0002132_abnormal_respiratory_system | 1.71607106 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.71100046 |
40 | MP0006276_abnormal_autonomic_nervous | 1.70333604 |
41 | MP0000013_abnormal_adipose_tissue | 1.69130165 |
42 | MP0005075_abnormal_melanosome_morpholog | 1.67452973 |
43 | MP0002693_abnormal_pancreas_physiology | 1.65495092 |
44 | MP0003136_yellow_coat_color | 1.61511109 |
45 | MP0003186_abnormal_redox_activity | 1.58851876 |
46 | MP0005551_abnormal_eye_electrophysiolog | 1.58530544 |
47 | MP0001188_hyperpigmentation | 1.58213233 |
48 | MP0002139_abnormal_hepatobiliary_system | 1.55958751 |
49 | MP0005379_endocrine/exocrine_gland_phen | 1.55884532 |
50 | MP0009764_decreased_sensitivity_to | 1.54499376 |
51 | MP0002277_abnormal_respiratory_mucosa | 1.53663042 |
52 | MP0009046_muscle_twitch | 1.53215900 |
53 | MP0000716_abnormal_immune_system | 1.51119972 |
54 | MP0009697_abnormal_copulation | 1.51085456 |
55 | MP0010329_abnormal_lipoprotein_level | 1.50030517 |
56 | MP0004043_abnormal_pH_regulation | 1.49974096 |
57 | MP0001853_heart_inflammation | 1.48846820 |
58 | MP0002166_altered_tumor_susceptibility | 1.48206265 |
59 | MP0002138_abnormal_hepatobiliary_system | 1.47762080 |
60 | MP0001764_abnormal_homeostasis | 1.47174064 |
61 | MP0006072_abnormal_retinal_apoptosis | 1.45745971 |
62 | MP0008469_abnormal_protein_level | 1.44068609 |
63 | MP0000015_abnormal_ear_pigmentation | 1.43661855 |
64 | MP0001845_abnormal_inflammatory_respons | 1.43431820 |
65 | MP0005332_abnormal_amino_acid | 1.43020614 |
66 | MP0002909_abnormal_adrenal_gland | 1.41751593 |
67 | MP0005409_darkened_coat_color | 1.41673311 |
68 | MP0003183_abnormal_peptide_metabolism | 1.41328307 |
69 | MP0002398_abnormal_bone_marrow | 1.39761711 |
70 | MP0000372_irregular_coat_pigmentation | 1.38355511 |
71 | MP0002405_respiratory_system_inflammati | 1.38354208 |
72 | MP0002822_catalepsy | 1.31855145 |
73 | MP0003195_calcinosis | 1.29751470 |
74 | MP0005464_abnormal_platelet_physiology | 1.27746066 |
75 | MP0002006_tumorigenesis | 1.25839694 |
76 | MP0005310_abnormal_salivary_gland | 1.24702578 |
77 | MP0005174_abnormal_tail_pigmentation | 1.24254296 |
78 | MP0002653_abnormal_ependyma_morphology | 1.24248380 |
79 | MP0005408_hypopigmentation | 1.23240637 |
80 | MP0002638_abnormal_pupillary_reflex | 1.22238612 |
81 | MP0005253_abnormal_eye_physiology | 1.21414868 |
82 | MP0003252_abnormal_bile_duct | 1.20628678 |
83 | MP0003011_delayed_dark_adaptation | 1.17861173 |
84 | MP0004782_abnormal_surfactant_physiolog | 1.17087637 |
85 | MP0010155_abnormal_intestine_physiology | 1.17045935 |
86 | MP0005084_abnormal_gallbladder_morpholo | 1.16763193 |
87 | MP0004147_increased_porphyrin_level | 1.16069399 |
88 | MP0002429_abnormal_blood_cell | 1.15869441 |
89 | MP0000689_abnormal_spleen_morphology | 1.15699808 |
90 | MP0003866_abnormal_defecation | 1.13490823 |
91 | MP0009745_abnormal_behavioral_response | 1.12891242 |
92 | MP0001944_abnormal_pancreas_morphology | 1.11470789 |
93 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11204028 |
94 | MP0006292_abnormal_olfactory_placode | 1.10266986 |
95 | MP0009780_abnormal_chondrocyte_physiolo | 1.09157924 |
96 | MP0004510_myositis | 1.08013396 |
97 | MP0002722_abnormal_immune_system | 1.07846369 |
98 | MP0005085_abnormal_gallbladder_physiolo | 1.05201619 |
99 | MP0000230_abnormal_systemic_arterial | 1.03375632 |
100 | MP0004142_abnormal_muscle_tone | 1.02934233 |
101 | MP0001984_abnormal_olfaction | 1.01666295 |
102 | MP0002735_abnormal_chemical_nociception | 1.00434028 |
103 | MP0004130_abnormal_muscle_cell | 0.99408699 |
104 | MP0002272_abnormal_nervous_system | 0.97451810 |
105 | MP0003880_abnormal_central_pattern | 0.97182106 |
106 | MP0000631_abnormal_neuroendocrine_gland | 0.96527247 |
107 | MP0001756_abnormal_urination | 0.96181623 |
108 | MP0009643_abnormal_urine_homeostasis | 0.94515575 |
109 | MP0001765_abnormal_ion_homeostasis | 0.92746849 |
110 | MP0002118_abnormal_lipid_homeostasis | 0.91981050 |
111 | MP0002095_abnormal_skin_pigmentation | 0.91297037 |
112 | MP0002078_abnormal_glucose_homeostasis | 0.91094124 |
113 | MP0001533_abnormal_skeleton_physiology | 0.90819278 |
114 | MP0000343_altered_response_to | 0.90672316 |
115 | MP0003646_muscle_fatigue | 0.89256922 |
116 | MP0005386_behavior/neurological_phenoty | 0.88318663 |
117 | MP0004924_abnormal_behavior | 0.88318663 |
118 | MP0002736_abnormal_nociception_after | 0.87722060 |
119 | MP0005360_urolithiasis | 0.87647968 |
120 | MP0001664_abnormal_digestion | 0.87500267 |
121 | MP0005448_abnormal_energy_balance | 0.86685916 |
122 | MP0006036_abnormal_mitochondrial_physio | 0.86128084 |
123 | MP0002102_abnormal_ear_morphology | 0.86109744 |
124 | MP0000538_abnormal_urinary_bladder | 0.84760471 |
125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84654051 |
126 | MP0001970_abnormal_pain_threshold | 0.82219661 |
127 | MP0003806_abnormal_nucleotide_metabolis | 0.81589492 |
128 | MP0009763_increased_sensitivity_to | 0.80920445 |
129 | MP0001663_abnormal_digestive_system | 0.80816909 |
130 | MP0008260_abnormal_autophagy | 0.79670010 |
131 | MP0002009_preneoplasia | 0.78924424 |
132 | MP0005389_reproductive_system_phenotype | 0.78181134 |
133 | MP0003953_abnormal_hormone_level | 0.76705324 |
134 | MP0005058_abnormal_lysosome_morphology | 0.76562152 |
135 | MP0005365_abnormal_bile_salt | 0.76485924 |
136 | MP0005636_abnormal_mineral_homeostasis | 0.75593373 |
137 | MP0002933_joint_inflammation | 0.75210179 |
138 | MP0000858_altered_metastatic_potential | 0.74686565 |
139 | MP0004947_skin_inflammation | 0.74162052 |
140 | MP0003283_abnormal_digestive_organ | 0.74160580 |
141 | MP0002064_seizures | 0.74114409 |
142 | MP0009765_abnormal_xenobiotic_induced | 0.71968131 |
143 | MP0005535_abnormal_body_temperature | 0.71735144 |
144 | MP0000703_abnormal_thymus_morphology | 0.71155896 |
145 | MP0001501_abnormal_sleep_pattern | 0.69488753 |
146 | MP0001968_abnormal_touch/_nociception | 0.69434087 |
147 | MP0004019_abnormal_vitamin_homeostasis | 0.66544009 |
148 | MP0001348_abnormal_lacrimal_gland | 0.66471846 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Autoimmune thrombocytopenia (HP:0001973) | 5.89579860 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 4.66807672 |
3 | Mitochondrial inheritance (HP:0001427) | 4.25127770 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.11554129 |
5 | Progressive macrocephaly (HP:0004481) | 3.83223860 |
6 | 3-Methylglutaconic aciduria (HP:0003535) | 3.81603689 |
7 | Acute encephalopathy (HP:0006846) | 3.78411531 |
8 | Hepatocellular necrosis (HP:0001404) | 3.74650874 |
9 | Hypothermia (HP:0002045) | 3.58835635 |
10 | Increased CSF lactate (HP:0002490) | 3.58646455 |
11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.52703743 |
12 | Increased IgM level (HP:0003496) | 3.48803579 |
13 | Renal Fanconi syndrome (HP:0001994) | 3.43589967 |
14 | Hepatic necrosis (HP:0002605) | 3.42878501 |
15 | Recurrent abscess formation (HP:0002722) | 3.32167461 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29791484 |
17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.28185190 |
18 | Enlarged epiphyses (HP:0010580) | 3.27371954 |
19 | Neonatal hypoglycemia (HP:0001998) | 3.25082412 |
20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.24059339 |
21 | Hypochromic anemia (HP:0001931) | 3.19697724 |
22 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.19190496 |
23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.13381125 |
24 | Hyperglycemia (HP:0003074) | 3.08011453 |
25 | Exertional dyspnea (HP:0002875) | 3.07996050 |
26 | Recurrent bacterial skin infections (HP:0005406) | 3.03594186 |
27 | Congenital stationary night blindness (HP:0007642) | 2.95875495 |
28 | Cerebral edema (HP:0002181) | 2.95455374 |
29 | Ketoacidosis (HP:0001993) | 2.92847343 |
30 | Pancreatic cysts (HP:0001737) | 2.88227607 |
31 | Eczematoid dermatitis (HP:0000976) | 2.86700425 |
32 | Optic disc pallor (HP:0000543) | 2.86492525 |
33 | Abnormality of T cell physiology (HP:0011840) | 2.74697128 |
34 | Ketosis (HP:0001946) | 2.74528083 |
35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.73027472 |
36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.73027472 |
37 | Birth length less than 3rd percentile (HP:0003561) | 2.71154085 |
38 | Myositis (HP:0100614) | 2.70904351 |
39 | Lip pit (HP:0100267) | 2.70086846 |
40 | Type II lissencephaly (HP:0007260) | 2.65367350 |
41 | Molar tooth sign on MRI (HP:0002419) | 2.63351928 |
42 | Abnormality of midbrain morphology (HP:0002418) | 2.63351928 |
43 | Nephronophthisis (HP:0000090) | 2.61939373 |
44 | Retrobulbar optic neuritis (HP:0100654) | 2.61697402 |
45 | Optic neuritis (HP:0100653) | 2.61697402 |
46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60560133 |
47 | Stomatitis (HP:0010280) | 2.59506094 |
48 | Increased intramyocellular lipid droplets (HP:0012240) | 2.53785001 |
49 | Increased serum lactate (HP:0002151) | 2.53645991 |
50 | Recurrent skin infections (HP:0001581) | 2.53533632 |
51 | Lactic acidosis (HP:0003128) | 2.52510510 |
52 | Abnormal hair whorl (HP:0010721) | 2.49625318 |
53 | Large for gestational age (HP:0001520) | 2.49082415 |
54 | Pancreatic fibrosis (HP:0100732) | 2.45663456 |
55 | Medial flaring of the eyebrow (HP:0010747) | 2.43121749 |
56 | Vacuolated lymphocytes (HP:0001922) | 2.36196529 |
57 | Glucose intolerance (HP:0000833) | 2.34722657 |
58 | IgM deficiency (HP:0002850) | 2.33424084 |
59 | Anterior segment dysgenesis (HP:0007700) | 2.32915774 |
60 | Orchitis (HP:0100796) | 2.31294291 |
61 | Leukodystrophy (HP:0002415) | 2.30984483 |
62 | Vasculitis (HP:0002633) | 2.30175097 |
63 | Respiratory difficulties (HP:0002880) | 2.29582701 |
64 | Exercise intolerance (HP:0003546) | 2.29302400 |
65 | Reduced antithrombin III activity (HP:0001976) | 2.29058406 |
66 | True hermaphroditism (HP:0010459) | 2.27503057 |
67 | Meningitis (HP:0001287) | 2.26317340 |
68 | IgG deficiency (HP:0004315) | 2.25898374 |
69 | Purpura (HP:0000979) | 2.25870573 |
70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25340434 |
71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24949872 |
72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24949872 |
73 | Obstructive lung disease (HP:0006536) | 2.24403869 |
74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24403869 |
75 | Autoimmune hemolytic anemia (HP:0001890) | 2.24054181 |
76 | Abnormality of T cell number (HP:0011839) | 2.23983264 |
77 | Severe combined immunodeficiency (HP:0004430) | 2.23870499 |
78 | Reticulocytopenia (HP:0001896) | 2.22582657 |
79 | Respiratory failure (HP:0002878) | 2.22200788 |
80 | Parakeratosis (HP:0001036) | 2.22141555 |
81 | Increased muscle lipid content (HP:0009058) | 2.21587401 |
82 | Abnormality of renal resorption (HP:0011038) | 2.21440058 |
83 | Joint hemorrhage (HP:0005261) | 2.20206281 |
84 | Abnormality of vitamin B metabolism (HP:0004340) | 2.20039270 |
85 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.19900342 |
86 | Lethargy (HP:0001254) | 2.18025675 |
87 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.16202433 |
88 | Abnormality of eosinophils (HP:0001879) | 2.15127090 |
89 | Abnormality of the renal medulla (HP:0100957) | 2.14735115 |
90 | Petechiae (HP:0000967) | 2.13052495 |
91 | Abnormality of macrophages (HP:0004311) | 2.12810337 |
92 | Mediastinal lymphadenopathy (HP:0100721) | 2.12509536 |
93 | Abnormal number of erythroid precursors (HP:0012131) | 2.10107975 |
94 | Epileptic encephalopathy (HP:0200134) | 2.09669363 |
95 | Agammaglobulinemia (HP:0004432) | 2.09650906 |
96 | Recurrent fungal infections (HP:0002841) | 2.08756693 |
97 | Type I transferrin isoform profile (HP:0003642) | 2.07485692 |
98 | Methylmalonic aciduria (HP:0012120) | 2.07455750 |
99 | Encephalitis (HP:0002383) | 2.07414928 |
100 | Methylmalonic acidemia (HP:0002912) | 2.07394264 |
101 | Eosinophilia (HP:0001880) | 2.05818629 |
102 | T lymphocytopenia (HP:0005403) | 2.05602766 |
103 | Neutropenia (HP:0001875) | 2.04744608 |
104 | Abnormality of urine glucose concentration (HP:0011016) | 2.04359273 |
105 | Glycosuria (HP:0003076) | 2.04359273 |
106 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.03754315 |
107 | Abnormality of secondary sexual hair (HP:0009888) | 2.02488898 |
108 | Abnormality of the axillary hair (HP:0100134) | 2.02488898 |
109 | Tubular atrophy (HP:0000092) | 2.01871056 |
110 | Gaze-evoked nystagmus (HP:0000640) | 2.01706759 |
111 | Attenuation of retinal blood vessels (HP:0007843) | 1.99685815 |
112 | Prolonged partial thromboplastin time (HP:0003645) | 1.98068688 |
113 | Abnormality of the renal cortex (HP:0011035) | 1.95362817 |
114 | Macrocytic anemia (HP:0001972) | 1.94537384 |
115 | Pallor (HP:0000980) | 1.93113063 |
116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92981297 |
117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92924221 |
118 | Renal tubular dysfunction (HP:0000124) | 1.92501150 |
119 | Hepatosplenomegaly (HP:0001433) | 1.91909028 |
120 | Granulocytopenia (HP:0001913) | 1.91741365 |
121 | Abnormal pupillary function (HP:0007686) | 1.91118439 |
122 | Hyperglycinemia (HP:0002154) | 1.90587845 |
123 | Abolished electroretinogram (ERG) (HP:0000550) | 1.89924696 |
124 | Hyperphosphaturia (HP:0003109) | 1.89910863 |
125 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.89696616 |
126 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.89696616 |
127 | Microvesicular hepatic steatosis (HP:0001414) | 1.89396066 |
128 | Myotonia (HP:0002486) | 1.88658537 |
129 | Chin dimple (HP:0010751) | 1.88634208 |
130 | Hyperventilation (HP:0002883) | 1.87978091 |
131 | Gastrointestinal stroma tumor (HP:0100723) | 1.87237129 |
132 | Hypergammaglobulinemia (HP:0010702) | 1.85872333 |
133 | Combined immunodeficiency (HP:0005387) | 1.85372184 |
134 | Hypoplasia of the thymus (HP:0000778) | 1.84917870 |
135 | Panhypogammaglobulinemia (HP:0003139) | 1.84745854 |
136 | Thyroiditis (HP:0100646) | 1.84637330 |
137 | Abnormality of T cells (HP:0002843) | 1.83403178 |
138 | Abnormality of glycolysis (HP:0004366) | 1.82591567 |
139 | Increased serum pyruvate (HP:0003542) | 1.82591567 |
140 | Hypoproteinemia (HP:0003075) | 1.80405691 |
141 | Abnormality of vitamin metabolism (HP:0100508) | 1.79930583 |
142 | Abnormal drinking behavior (HP:0030082) | 1.79396413 |
143 | Polydipsia (HP:0001959) | 1.79396413 |
144 | Leukocytosis (HP:0001974) | 1.78807979 |
145 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78734607 |
146 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78597263 |
147 | Systemic lupus erythematosus (HP:0002725) | 1.78385888 |
148 | Alveolar cell carcinoma (HP:0006519) | 1.77667410 |
149 | Lymphopenia (HP:0001888) | 1.77639444 |
150 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73832148 |
151 | Constricted visual fields (HP:0001133) | 1.73723362 |
152 | Hypomagnesemia (HP:0002917) | 1.73590946 |
153 | Opisthotonus (HP:0002179) | 1.72373325 |
154 | Abnormal albumin level (HP:0012116) | 1.71413894 |
155 | Hypoalbuminemia (HP:0003073) | 1.71413894 |
156 | Retinal dysplasia (HP:0007973) | 1.71253740 |
157 | Hypobetalipoproteinemia (HP:0003563) | 1.70975225 |
158 | Hemiparesis (HP:0001269) | 1.70830822 |
159 | Chronic diarrhea (HP:0002028) | 1.70662076 |
160 | Absent/shortened dynein arms (HP:0200106) | 1.69547200 |
161 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69547200 |
162 | Abnormality of macular pigmentation (HP:0008002) | 1.68600102 |
163 | Chronic hepatic failure (HP:0100626) | 1.68022991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PIK3CA | 4.70172976 |
2 | FRK | 3.65895029 |
3 | TXK | 3.29071912 |
4 | NME2 | 3.14341831 |
5 | MAP3K12 | 2.92148073 |
6 | IRAK4 | 2.76229860 |
7 | MAP3K14 | 2.70535094 |
8 | MAP4K2 | 2.65083171 |
9 | CASK | 2.52993157 |
10 | IRAK3 | 2.49406687 |
11 | STK16 | 2.48089744 |
12 | CAMKK2 | 2.43476995 |
13 | OXSR1 | 2.38368178 |
14 | IKBKE | 2.34860753 |
15 | PBK | 2.06630618 |
16 | BLK | 2.05079518 |
17 | TNIK | 2.01760206 |
18 | TLK1 | 1.96543071 |
19 | MST4 | 1.88012031 |
20 | PIM2 | 1.85941745 |
21 | TBK1 | 1.75275380 |
22 | GRK7 | 1.72939757 |
23 | TEC | 1.60687980 |
24 | ADRBK2 | 1.59800229 |
25 | TYK2 | 1.57292828 |
26 | IKBKB | 1.55713101 |
27 | MAP4K1 | 1.48914130 |
28 | ZAP70 | 1.46070693 |
29 | BMPR2 | 1.45159537 |
30 | MYLK | 1.44970022 |
31 | KIT | 1.43942479 |
32 | JAK3 | 1.41487876 |
33 | BMPR1B | 1.40498662 |
34 | MAP2K3 | 1.40084842 |
35 | MAP3K6 | 1.38262849 |
36 | ARAF | 1.37586648 |
37 | DAPK2 | 1.37324760 |
38 | NME1 | 1.37046955 |
39 | SRPK1 | 1.36286981 |
40 | NUAK1 | 1.34777888 |
41 | SYK | 1.32687441 |
42 | PINK1 | 1.31107574 |
43 | BTK | 1.28501436 |
44 | WNK4 | 1.25758378 |
45 | IRAK1 | 1.24473296 |
46 | ZAK | 1.20913591 |
47 | YES1 | 1.18485609 |
48 | MAP2K7 | 1.18004962 |
49 | IRAK2 | 1.17501344 |
50 | EIF2AK2 | 1.15075596 |
51 | MUSK | 1.14674307 |
52 | PRKCG | 1.14671972 |
53 | MKNK2 | 1.13657446 |
54 | WNK3 | 1.11690060 |
55 | RIPK4 | 1.11051198 |
56 | MAP2K4 | 1.10640848 |
57 | ACVR1B | 1.10269177 |
58 | LCK | 1.07470892 |
59 | CSNK1G1 | 1.05399583 |
60 | STK39 | 1.01831608 |
61 | VRK1 | 0.97253911 |
62 | MKNK1 | 0.95863192 |
63 | LYN | 0.95363922 |
64 | NLK | 0.95046803 |
65 | MAPK12 | 0.94239597 |
66 | PDK2 | 0.94152261 |
67 | FGFR4 | 0.92303108 |
68 | MAP3K11 | 0.91750263 |
69 | CAMK1D | 0.90242432 |
70 | CSNK1G2 | 0.90046738 |
71 | KDR | 0.88527436 |
72 | EIF2AK3 | 0.87690709 |
73 | RET | 0.87292534 |
74 | ITK | 0.86669621 |
75 | SIK3 | 0.85496739 |
76 | GRK5 | 0.83467390 |
77 | GRK6 | 0.82255304 |
78 | DYRK2 | 0.79087904 |
79 | BCKDK | 0.78325288 |
80 | TNK2 | 0.77917003 |
81 | NTRK3 | 0.74643823 |
82 | TAOK3 | 0.73549368 |
83 | MARK3 | 0.72894635 |
84 | ABL2 | 0.71650159 |
85 | PLK4 | 0.71174647 |
86 | JAK1 | 0.71029085 |
87 | NEK9 | 0.70999785 |
88 | PHKG1 | 0.70962189 |
89 | PHKG2 | 0.70962189 |
90 | INSRR | 0.70484290 |
91 | PIK3CG | 0.69916830 |
92 | STK11 | 0.69901528 |
93 | CLK1 | 0.68290337 |
94 | BCR | 0.67986137 |
95 | CSNK1A1L | 0.67646273 |
96 | PRKCQ | 0.67591898 |
97 | MAPKAPK5 | 0.67008783 |
98 | PAK3 | 0.64956249 |
99 | CHUK | 0.63960554 |
100 | EIF2AK1 | 0.63906561 |
101 | STK10 | 0.61724632 |
102 | RPS6KA5 | 0.61614792 |
103 | PIM1 | 0.58316197 |
104 | PKN1 | 0.57907060 |
105 | TIE1 | 0.57758270 |
106 | MAP2K6 | 0.57288710 |
107 | VRK2 | 0.56788691 |
108 | MAP3K13 | 0.56012521 |
109 | MAPK13 | 0.55344791 |
110 | ERBB3 | 0.55281024 |
111 | CAMKK1 | 0.55213397 |
112 | GRK1 | 0.54977097 |
113 | MINK1 | 0.54649822 |
114 | MAP3K5 | 0.53852479 |
115 | CDK19 | 0.53253508 |
116 | AKT3 | 0.52832218 |
117 | CSK | 0.52626373 |
118 | PRKCD | 0.52368466 |
119 | CSNK1G3 | 0.52225821 |
120 | CSF1R | 0.51588672 |
121 | BRAF | 0.51248752 |
122 | PRPF4B | 0.50230143 |
123 | FES | 0.50107815 |
124 | STK24 | 0.49387989 |
125 | CAMK1G | 0.48171090 |
126 | MAPK4 | 0.47615597 |
127 | PTK2B | 0.46496857 |
128 | CDK3 | 0.44910922 |
129 | CAMK2A | 0.44750109 |
130 | NEK6 | 0.44701755 |
131 | TSSK6 | 0.44470728 |
132 | HCK | 0.44369422 |
133 | MAPK15 | 0.44201865 |
134 | PRKACA | 0.43702291 |
135 | PRKCA | 0.42588324 |
136 | PRKG1 | 0.42446092 |
137 | IGF1R | 0.41697192 |
138 | MATK | 0.41608961 |
139 | BUB1 | 0.41086031 |
140 | CAMK1 | 0.39173367 |
141 | DAPK3 | 0.38894262 |
142 | PRKCI | 0.38594200 |
143 | TESK2 | 0.38375188 |
144 | MAP3K4 | 0.37533788 |
145 | PRKCE | 0.36947440 |
146 | CSNK2A1 | 0.36396862 |
147 | STK4 | 0.35391822 |
148 | ADRBK1 | 0.34746019 |
149 | CSNK1D | 0.34688171 |
150 | STK3 | 0.34044096 |
151 | MOS | 0.32967727 |
152 | PDK1 | 0.32950161 |
153 | LIMK1 | 0.32608048 |
154 | TGFBR2 | 0.31425345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.22255773 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.95282211 |
3 | Ribosome_Homo sapiens_hsa03010 | 3.47717810 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.30565843 |
5 | Proteasome_Homo sapiens_hsa03050 | 3.10291099 |
6 | Protein export_Homo sapiens_hsa03060 | 2.81846663 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74705040 |
8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.54487705 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52340582 |
10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.33743173 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.32718801 |
12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31444584 |
13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.27478078 |
14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.10782355 |
15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.01542305 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.00189192 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94088892 |
18 | RNA polymerase_Homo sapiens_hsa03020 | 1.82281381 |
19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.79556684 |
20 | Asthma_Homo sapiens_hsa05310 | 1.75566222 |
21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.61352926 |
22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59774027 |
23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55358186 |
24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52062395 |
25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48378874 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36473821 |
27 | Phototransduction_Homo sapiens_hsa04744 | 1.32619283 |
28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31368058 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29614946 |
30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29073291 |
31 | Measles_Homo sapiens_hsa05162 | 1.27469797 |
32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27012033 |
33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26331233 |
34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.25749555 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23700272 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20019996 |
37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19873445 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16802560 |
39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15000490 |
40 | Peroxisome_Homo sapiens_hsa04146 | 1.14939681 |
41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11941919 |
42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09863493 |
43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09739905 |
44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09598934 |
45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08338010 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08145984 |
47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06823728 |
48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06168626 |
49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05779611 |
50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03429097 |
51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02507369 |
52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00527379 |
53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98963330 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98464846 |
55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97226721 |
56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96546804 |
57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95479288 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95131415 |
59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94562124 |
60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94333076 |
61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91591220 |
62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91025089 |
63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90763170 |
64 | Insulin secretion_Homo sapiens_hsa04911 | 0.90224738 |
65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87375918 |
66 | Phagosome_Homo sapiens_hsa04145 | 0.84706154 |
67 | Legionellosis_Homo sapiens_hsa05134 | 0.83360178 |
68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82494759 |
69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81327093 |
70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80788120 |
71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80569266 |
72 | Pertussis_Homo sapiens_hsa05133 | 0.79373401 |
73 | Malaria_Homo sapiens_hsa05144 | 0.78785058 |
74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76163817 |
75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75953525 |
76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75804092 |
77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74758257 |
78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74404773 |
79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71692736 |
80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71318066 |
81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69712134 |
82 | ABC transporters_Homo sapiens_hsa02010 | 0.69174605 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68778726 |
84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65903994 |
85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64502588 |
86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63720988 |
87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63489885 |
88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62138837 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.61692849 |
90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60740343 |
91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60331585 |
92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60138701 |
93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59503355 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55842395 |
95 | Influenza A_Homo sapiens_hsa05164 | 0.55071639 |
96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53411149 |
97 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53186904 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52663800 |
99 | Purine metabolism_Homo sapiens_hsa00230 | 0.52497471 |
100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51590592 |
101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50904302 |
102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50010195 |
103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49304543 |
104 | Tuberculosis_Homo sapiens_hsa05152 | 0.48855586 |
105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48691558 |
106 | Homologous recombination_Homo sapiens_hsa03440 | 0.48674608 |
107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48168289 |
108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45823984 |
109 | Renin secretion_Homo sapiens_hsa04924 | 0.45051424 |
110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44852507 |
111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43689793 |
112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43435202 |
113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42803350 |
114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41190699 |
115 | Salivary secretion_Homo sapiens_hsa04970 | 0.40991866 |
116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39854591 |
117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39283537 |
118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38969375 |
119 | Salmonella infection_Homo sapiens_hsa05132 | 0.38540865 |
120 | Mismatch repair_Homo sapiens_hsa03430 | 0.38090204 |
121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37530748 |
122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37333013 |
123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36601767 |
124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36327929 |
125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35499082 |
126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35359913 |
127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34883808 |
128 | Hepatitis C_Homo sapiens_hsa05160 | 0.34111770 |
129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33974404 |
130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33228044 |
131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30324368 |
132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29870969 |
133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29712929 |